Clinical Trial Update: Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating exenatide in people with type 2 diabetes and diastolic heart failure was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Diabetes Mellitus, Type 2, Heart Failure, Diastolic | Phase 4 | Status: TERMINATED | Results posted: 2017-09-21